Literature DB >> 7666558

Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.

S Barksdale1, C C Baker.   

Abstract

Activation of the late promoter (PL) of bovine papillomavirus type 1 (BPV-1) is dependent on the differentiation state of keratinocytes and occurs in the upper layers of the bovine fibropapilloma. In this study, we show by in situ hybridization that a differentiation-specific pattern of BPV-1 late RNA splicing is also seen in the fibropapilloma. RNAs containing the 7385/3605 and 3764/5609 splice junctions were confined to the granular cell layer. In contrast, RNAs containing the 7385/3225 splice junction were present in both the granular and spinous layers. The switch in splice site usage in the granular cell layer limits the expression of the mRNA encoding the major capsid protein to these most terminally differentiated cells. Thus, BPV-1 late mRNA expression is regulated at both transcriptional and posttranscriptional levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666558      PMCID: PMC189558     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project.

Authors:  P Senapathy; M B Shapiro; N L Harris
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

Review 4.  Animal papillomaviruses.

Authors:  W D Lancaster; C Olson
Journal:  Microbiol Rev       Date:  1982-06

5.  Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.

Authors:  X W Jin; L M Cowsert; W P Pilacinski; A B Jenson
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

6.  Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.

Authors:  S K Barksdale; C C Baker
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  The primary structure and genetic organization of the bovine papillomavirus type 1 genome.

Authors:  E Y Chen; P M Howley; A D Levinson; P H Seeburg
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

8.  Transcriptional organization of bovine papillomavirus type 1.

Authors:  L W Engel; C A Heilman; P M Howley
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

9.  Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue.

Authors:  S Burnett; N Jareborg; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues.

Authors:  C C Baker; P M Howley
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

View more
  21 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

Review 3.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

4.  Imaging the alternative silencing of FGFR2 exon IIIb in vivo.

Authors:  Vivian I Bonano; Sebastian Oltean; Robert M Brazas; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2006-10-26       Impact factor: 4.942

5.  Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.

Authors:  Z M Zheng; P J He; C C Baker
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Internal polyadenylation of the parvovirus B19 precursor mRNA is regulated by alternative splicing.

Authors:  Wuxiang Guan; Qinfeng Huang; Fang Cheng; Jianming Qiu
Journal:  J Biol Chem       Date:  2011-05-27       Impact factor: 5.157

9.  Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.

Authors:  Z M Zheng; P J He; C C Baker
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex.

Authors:  Sarah A Cumming; Maria G McPhillips; Thanaporn Veerapraditsin; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.